Literature DB >> 13818037

Inhibitory effect of new anticholinergics on the basal and secretin-stimulated pancreatic secretion in patients with and without pancreatic disease: therapeutic and theoretic implications.

D A DREILING, H D JANOWITZ.   

Abstract

Entities:  

Keywords:  GASTROINTESTINAL HORMONES/pharmacology; PANCREAS/pharmacology; PARASYMPATHOLYTICS/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13818037     DOI: 10.1007/bf02290198

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  21 in total

1.  The secretion of electrolytes by the human pancreas; the effect of diamox, ACTH, and disease.

Authors:  D A DREILING; H D JANOWITZ
Journal:  Am J Dig Dis       Date:  1959-02

2.  [The problem of therapy of pancreatitis].

Authors:  E WERLE; K TAUBER; W HARTENBACH; M M FORELL
Journal:  Munch Med Wochenschr       Date:  1958-08-29

3.  Anticholinergic drugs; survey of the literature and some experimental observations.

Authors:  W H BACHRACH
Journal:  Am J Dig Dis       Date:  1958-10

4.  The secretion of electrolytes by the human pancreas.

Authors:  D A DREILING; H D JANOWITZ
Journal:  Gastroenterology       Date:  1956-03       Impact factor: 22.682

5.  Some relationships between adrenal medullary and cortical substances and exocrine function of the pancreas in man.

Authors:  J W HINTON; R B PFEFFER
Journal:  Gastroenterology       Date:  1956-12       Impact factor: 22.682

6.  The comparative anticholinergic activity of a series of derivatives of 3-hydroxy piperidine.

Authors:  J P LONG; H H KEASLING
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1954-10

7.  Inhibition of human pancreatic secretion by diamox (carbonic anhydrase inhibitor; therapeutic implications in pancreatitis.

Authors:  D A DREILING; H D JANOWITZ
Journal:  Surg Forum       Date:  1955

8.  The mechanism of pancreatic digestion-the function of secretin.

Authors:  J Mellanby
Journal:  J Physiol       Date:  1925-05-21       Impact factor: 5.182

9.  Antispasmodic effects and toxicity of n-ethyl-3-piperidyldiphenylacetate hydrochloride (JB-305) with special reference to its action on the sphincter of Oddi of the dog.

Authors:  J Y P CHEN; H BECKMAN
Journal:  J Pharmacol Exp Ther       Date:  1952-03       Impact factor: 4.030

10.  Some effects of banthine on pancreatic secretion.

Authors:  D ANNIS; G A HALLENBECK
Journal:  Gastroenterology       Date:  1951-04       Impact factor: 22.682

View more
  8 in total

1.  SUPPRESSION OF SECRETION AND CONTROL OF PAIN IN PANCREATITIS.

Authors:  B B WEISIGER
Journal:  Am J Dig Dis       Date:  1964-11

2.  EXPERIENCES WITH ACUTE PANCREATIC INFLAMMATORY DISEASE AT A SMALL CITY HOSPITAL.

Authors:  A SINGER; D A DREILING
Journal:  Am J Dig Dis       Date:  1965-09

3.  Chronic duodenal obstruction: a mechano-vascular etiology of pancreatitis. II. Experimental observations.

Authors:  A PAULINO-NETTO; D A DREILING
Journal:  Am J Dig Dis       Date:  1960-12

4.  The relationship between taurocholate secretion rate and bile production in the unanesthetized dog during cholinergic blockade and during secretin administration.

Authors:  R PREISIG; H L COOPER; H O WHEELER
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

5.  Mechanism of release of endogenous cholecystokinin by jejunal amino acid perfusion in man.

Authors:  A Ertan; F P Brooks; D Arvan; N Williams
Journal:  Am J Dig Dis       Date:  1975-09

6.  Effect of diazepam and hyoscine butylbromide on response to secretin and cholecystokinin-pancreozymin in man.

Authors:  J H Saunders; G Masoero; K G Wormsley
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

7.  Inhibition of pancreatic secretion in man by cigarette smoking.

Authors:  T E Bynum; T E Solomon; L R Johnson; E D Jacobson
Journal:  Gut       Date:  1972-05       Impact factor: 23.059

8.  Bile production in fasted and fed primates.

Authors:  S M Strasberg; K A Siminovitch; R G Ilson
Journal:  Ann Surg       Date:  1974-09       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.